52 results
DEFM14A
RVMD
Revolution Medicines, Inc.
29 Sep 23
Proxy related to merger
4:19pm
officer’s “disability”, or by the EQRx executive officer for “good reason” (as such terms are defined in each retention bonus agreement), all subject
424B3
RVMD
Revolution Medicines, Inc.
29 Sep 23
Prospectus supplement
4:17pm
by EQRx (or its subsidiaries or successors) without “cause” or because of the EQRx executive officer’s “disability”, or by the EQRx executive officer
S-4/A
u8ggxck jg3b3xtcj4
27 Sep 23
Registration of securities issued in business combination transactions (amended)
5:25pm
S-4
tn7tb2zq7
13 Sep 23
Registration of securities issued in business combination transactions
5:20pm
425
6hyxs7
1 Aug 23
Business combination disclosure
5:22pm
425
anzcn ceklajds4gs
1 Aug 23
Business combination disclosure
7:15am
8-K
EX-2.1
h2mcogzbz4m 7694b
1 Aug 23
Form of Parent Stockholder Voting Agreement
7:10am
8-K
EX-1.1
x6h2qp a4nes
22 Jul 22
Other Events
4:02pm
424B5
13ob 49te
20 Jul 22
Prospectus supplement for primary offering
4:02pm
424B5
ugpaq23f1f0j0ueqi
19 Jul 22
Prospectus supplement for primary offering
4:01pm
DEF 14A
hbnh4ok
28 Apr 21
Definitive proxy
4:33pm
424B4
2r45nauru5pt0cuhyks
5 Feb 21
Prospectus supplement with pricing info
12:00am